FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

14749511000001100: Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
51677501000001116 Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
51677601000001117 Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Is a Cilazapril 2.5mg tablets true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Is a Cilazapril 2.5mg tablets false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Is a Product containing precisely cilazapril 2.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient Cilazapril false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Is a Vascace true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Cilazapril monohydrate true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Has basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Is pack of False Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) 28 tablet Has AMP True Vascace 2.5mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start